Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Lilly share buyback program

Executive Summary

Lilly repurchased approximately 2.1 mil. shares during the first half of 2002 for a total of $181 mil., company reports in second quarter 10-Q. As with many pharmaceutical company stock buy-backs over the past 18 months, the purchases do not currently look like a great investment: the average price Lilly paid per share during the first half of the year ($86.19) is more than 40% higher than the current share price of $60...
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS040374

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel